Second-line FOLFOX is not the standard of care for all patients with advanced biliary tract cancer—a commentary from the Young International Society of Geriatric Oncology

G. Liposits; S. P. Arora; N. M.L. Battisti; E. Soto-Perez-de-Celis; K. P. Loh; G. R. Williams

doi:10.1016/j.annonc.2023.02.007

Second-line FOLFOX is not the standard of care for all patients with advanced biliary tract cancer—a commentary from the Young International Society of Geriatric Oncology

G. Liposits, S. P. Arora, N. M.L. Battisti, E. Soto-Perez-de-Celis, K. P. Loh, G. R. Williams

Producción científica: Letter › revisión exhaustiva

Idioma original	English (US)
Páginas (desde-hasta)	555-556
Número de páginas	2
Publicación	Annals of Oncology
Volumen	34
N.º	6
DOI	https://doi.org/10.1016/j.annonc.2023.02.007
Estado	Published - jun 2023

ASJC Scopus subject areas

Hematology
Oncology

Acceder al documento

10.1016/j.annonc.2023.02.007

Otros archivos y enlaces

Citar esto

@article{45277bcafee84afb943afdef6b94256e,

title = "Second-line FOLFOX is not the standard of care for all patients with advanced biliary tract cancer—a commentary from the Young International Society of Geriatric Oncology",

author = "G. Liposits and Arora, {S. P.} and Battisti, {N. M.L.} and E. Soto-Perez-de-Celis and Loh, {K. P.} and Williams, {G. R.}",

note = "Funding Information: None declared. The authors have declared no conflicts of interest.",

year = "2023",

month = jun,

doi = "10.1016/j.annonc.2023.02.007",

language = "English (US)",

volume = "34",

pages = "555--556",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Elsevier Ltd",

number = "6",

}

TY - JOUR

T1 - Second-line FOLFOX is not the standard of care for all patients with advanced biliary tract cancer—a commentary from the Young International Society of Geriatric Oncology

AU - Liposits, G.

AU - Arora, S. P.

AU - Battisti, N. M.L.

AU - Soto-Perez-de-Celis, E.

AU - Loh, K. P.

AU - Williams, G. R.

N1 - Funding Information: None declared. The authors have declared no conflicts of interest.

PY - 2023/6

Y1 - 2023/6

UR - http://www.scopus.com/inward/record.url?scp=85161292055&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85161292055&partnerID=8YFLogxK

U2 - 10.1016/j.annonc.2023.02.007

DO - 10.1016/j.annonc.2023.02.007

M3 - Letter

C2 - 36813114

AN - SCOPUS:85161292055

SN - 0923-7534

VL - 34

SP - 555

EP - 556

JO - Annals of Oncology

JF - Annals of Oncology

IS - 6

ER -